跳至主要内容
临床试验/NCT03997825
NCT03997825已完成不适用

Five-Plus Year Follow-Up of SMART (Surgical Multicenter Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain) Trial

Relievant Medsystems, Inc.13 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2019年6月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
117
试验地点
13
主要终点
LS Mean Reduction in Oswestry Disability Index (ODI) From Baseline

研究概览

简要总结

The objective of this study is to evaluate long-term ongoing effectiveness of the Intracept Intraosseous Nerve Ablation System for the treatment of chronic low back pain.

详细描述

This is a prospective multi-center, nonintervention, observational, single arm post market data collection of the 5+ year effectiveness and satisfaction outcome for the SMART trial population.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • LBP at least 6 months from original SMART Trial
  • RF Ablation Arm from SMART Trial

排除标准

  • Control Arm Subjects from SMART Trial

结局指标

主要结局

LS Mean Reduction in Oswestry Disability Index (ODI) From Baseline

时间窗: Difference between baseline and 5 year post treatment measurements

Validated questionnaire of low back pain related disability. Comprised of 10 questions evaluating the impact of low back pain on activities of daily living. The ODI is scored on a scale of 0 (no disability) to 100 (complete disability), with categories of 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). Difference in mean ODI at baseline and 5 years post treatment measurements.

次要结局

  • LS Mean Reduction in VAS From Baseline(Difference between baseline and 5 year post treatment measurements)
  • Responder Rates(At 5 year post treatment)
  • Narcotics Use(Difference between baseline and 5 years post treatment.)
  • Injections(Difference from baseline percentage measurement to 5 years post treatment measurement)
  • Interventions(Measured form treatment data to 5 years post treatment visit date)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验